A Study of the Antidepressant Activity of Hypericum Perforatum on Animal Models

The treatment of non-selected depressed patients with a hydro-alcoholic extract of Hypericum perforatum has been reported to have an efficacy similar to that of classical antidepressants. The effects of H. perforatum on three animal depression models have been studied: (a) an acute form of escape deficit (ED) induced by unavoidable stress; (b) a chronic model of ED, which can be maintained by the administration of mild stressors on alternate days; (c) a model of anhedonia based on the finding that repeated stressors prevent the development of appetitive behavior induced by vanilla sugar in satiated rats fed ad libitum. H. perforatum: (i) acutely protects animals from the sequelae of unavoidable stress; (ii) reverts the chronic escape deficit state maintained by repeated stressors and (iii) preserves the animal’s capacity to acquire motivated appetitive behavior. Exposure to chronic stress not only induces escape deficit, but also decreases extraneuronal levels of dopamine in the nucleus accumbens shell; both behavioral and neurochemical effects are reverted by long-term treatment with antidepressants. Three-week treatment with H. perforatum reverted the chronic stress effect on extraneuronal dopamine in the nucleus accumbens. A consistent body of data in the literature suggests that, among the components of H. perforatum extract, hyperforin is the compound (or one of the compounds) responsible for the antidepressant activity. We compared the efficacy of the total extract with the efficacy of hyperforin after p. o. administration. In the acute-escape deficit model, hyperforin showed a potency of about ten times that of the total extract in protecting rats from the sequelae of unavoidable stress. Thus, hyperforin appears to be the most likely active component responsible for the antidepressant activity of H. perforatum.

References

• 1 Bhattacharya S-K, Chakrabarti A,Chatterjee S-S. Activity profiles of two hyperforin-containing hypericum extracts in behavioral models.  Pharmacopsychiat. 1998;  31 ( Suppl2) 22-29
• 2 Chatterjee S-S, Bhattacharya S-K, Wonnemann M, Singer A, Muller W-E. Hyperforin as a possible antidepressant component of hypericum extracts.  Life Sci. 1998;  63 499-510
• 3 De Montis M-G, Gambarana C, Ghiglieri O, Tagliamonte A. Reversal of stable behavioural modifications through NMDA receptor inhibition in rats.  Behav Pharmacol. 1995;  6 562-567
• 4 Gambarana C, Ghiglieri O, Taddei I, Tagliamonte A, De Montis M-G. Imipramine and fluoxetine prevent the stress-induced escape deficit in rats through a distinct mechanism of action.  Behav Pharmacol. 1995;  6 66-73
• 5 Gambarana C, Ghiglieri O, Tolu P, De Montis M -G, Giachetti D, Bombardelli E, Tagliamonte A. Efficacy of an Hypericum perforatum (St. John’s wort) extract in preventing and reverting a condition of escape deficit in rats.  Neuropsychopharmacol. 1999;  21 247-257
• 6 Gambarana C, Masi F, Tagliamonte A, Scheggi A, Ghiglieri O, De Montis M-G. A chronic stress which impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study.  J Neurochem. 1999;  72 2039-2046
• 7 Ghiglieri O, Gambarana C, Scheggi S, Tagliamonte A, Willner P, De Montis M-G. Palatable food induces an appetitive behaviour in satiated rats which can be inhibited by chronic stress.  Behav Pharmacol. 1997;  8 619-628
• 8 Hotopf M. St. John’s wort is more effective than placebo for treating depressive disorders.  Evidence-Based Med. 1999;  4 82
• 9 Linde K, Ramirez G, Mulrow C-D, Pauls A., Weidenhammer W, Melchart D. St. John’s wort for depression - an overview and meta-analysis of randomised clinical trials.  Br Med J. 1996;  313 253-258
• 10 Philipp M, Kohnen R, Hiller K-O. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.  Br Med J. 1999;  319 1534-1539